Breakthrough COVID-19 after Tixagevimab/Cilgavimab among Patients with Systemic Autoimmune Rheumatic Diseases.
JOURNAL OF RHEUMATOLOGY(2024)
关键词
autoimmune diseases,COVID-19,preexposure prophylaxis,tixagevimab/cilgavimab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要